Newest
BETR ▼ sold $13K · Tuffin Paula filed 2d agoBETR ▼ sold $14K · Nicholas J. Calamari filed 2d agoFBK ▲ bought $716K · INGRAM ORRIN H II filed 2d agoFBK ▲ bought $821K · INGRAM ORRIN H II filed 2d agoBEN ▼ sold $5.0M · FRANKLIN TEMPLETON INC filed 2d agoNAD ▼ sold $338K · Robert Young L filed 3d agoWSBC ▼ sold $15K · Rep. Michael A. Rulli filed 4d agoGOOG ▼ sold $100K · Rep. Michael A. Rulli filed 4d agoWMT ▼ sold $100K · Rep. Jonathan L. Jackson filed 4d agoVSAT ▼ sold $100K · Rep. Jonathan L. Jackson filed 4d agoTYG ▼ sold $15K · Rep. Jonathan L. Jackson filed 4d agoGH ▲ bought $50K · Rep. Jonathan L. Jackson filed 4d agoEL ▲ bought $100K · Rep. Jonathan L. Jackson filed 4d agoDDOG ▲ bought $100K · Rep. Jonathan L. Jackson filed 4d agoCPRT ▼ sold $553K · Morefield Diane M filed 4d agoPTON ▼ sold $154K · Kirol Charles Peter filed 4d agoEME ▲ bought $1K · MCEVOY M KEVIN filed 4d agoEME ▲ bought $826 · MCEVOY M KEVIN filed 4d ago

Company / CIK 0001519751

Fortune Brands Innovations, Inc.

Ticker
FBIN
Size, estimated from filings
Mid cap ($2B – $10B)
Insiders on file
20
Members of Congress who traded it
1
Federal contracts on record
none matched
Lobbying filings on record
5
SEC filings
EDGAR ↗
Latest trade on record
September 28, 2026

Fortune Brands Innovations, Inc. (FBIN) has 20 insiders on file who disclosed 57 transactions in the last 12 months (7 open-market buys, 10 sales, about $33.5M at reported prices), and 7 congressional trades in its stock are on record. No federal contract award that started in the last 180 days was found for a recipient with exactly this name, and 3 lobbying filings naming it as client report $70K in 2026.

Last updated September 29, 2026 · Sources: SEC EDGAR; USAspending; Senate LDA

Fortune Brands Innovations, Inc. in charts

Who is trading this stock

Which people account for the buying and selling over the last 12 months?

BoughtSold

8 people account for the disclosed buying and selling in Fortune Brands Innovations, Inc. over the last 12 months; the most active is GARDEN EDWARD P with $29M.

Lobbying spend by quarter

How much has Fortune Brands Innovations, Inc. reported spending on federal lobbying?

Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26

Fortune Brands Innovations, Inc. reported $170K in lobbying over the last eight quarters, from filings matched by exact company name.

Insiders

NameRoleRowsBoughtSoldLast filed
Foley Brendan MDirector100October 20, 2026
Finan IrialDirector600September 29, 2026
Clifford Peter GEVP & CFO400September 29, 2026
Novak Matthew EdwardEVP, Chief Supply Chain502August 10, 2026
Singh Jesse GChief Executive Officer530August 10, 2026
Lee John Dong GuEVP Chief Digiital Innovation502August 3, 2026
Ries KarenSVP & Chief Accounting Officer502August 3, 2026
Fink Nicholas I.President & CEO201July 14, 2026
Barry David V.Chief Operating Officer100July 2, 2026
GARDEN EDWARD PDirector640June 11, 2026
Chande AmeeDirector100May 7, 2026
HACKETT ANN FDirector100May 7, 2026
Kilsby Susan SDirector100May 7, 2026
MACKAY A D DAVIDDirector100May 7, 2026
Perry Jeffery S.Director100May 7, 2026
PUGLIESE STEPHANIE L.Director100May 7, 2026
George Ashley E.Interim CFO100May 6, 2026
Papesh KristinEVP and CHRO502March 3, 2026
Donoghue Hiranda SEVP Chief Legal & Secretary401March 3, 2026
Baksht JonathanEVP and CFO200February 27, 2026

Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.

Members of Congress who traded FBIN

From periodic transaction reports that name the company's stock. Amounts are the sums of the ranges as filed. Every row is on the FBIN page.

MemberSeatTradesBoughtSoldRange as filedLatest
April McClain DelaneyRepresentative (MD, District 6), Democrat707$7,007–$105KMay 7, 2026

Insider transactions

Download CSV65 rows · 24 KB · insider and congressional rows for this ticker · all downloads

FilerSecuritySideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
Clifford Peter GFBINOther ASeptember 28, 2026September 29, 20261d130,000——derivativeForm 4 ↗
Clifford Peter GFBINOther ASeptember 28, 2026September 29, 20261d65,000——derivativeForm 4 ↗
Clifford Peter GFBINOther ASeptember 28, 2026September 29, 20261d10,212——derivativeForm 4 ↗
Clifford Peter GFBINOther ASeptember 28, 2026September 29, 20261d3,651——Form 4 ↗
Finan IrialFBINOther ASeptember 28, 2026September 29, 20261d943——Form 4 ↗
Singh Jesse GFBINBuy PAugust 7, 2026August 10, 20263d19,560$51$996KForm 4 ↗
Singh Jesse GFBINBuy PAugust 6, 2026August 10, 20264d5,281$52$276KForm 4 ↗
Singh Jesse GFBINBuy PAugust 6, 2026August 10, 20264d14,444$51$743KForm 4 ↗
Novak Matthew EdwardFBINSell SAugust 7, 2026August 10, 20263d600$51$31KForm 4 ↗
Ries KarenFBINSell FJuly 31, 2026August 3, 20263d257$49$13KForm 4 ↗
Lee John Dong GuFBINSell FJuly 31, 2026August 3, 20263d260$49$13KForm 4 ↗
Barry David V.FBINOther AJuly 1, 2026July 2, 20261d25,000——derivativeForm 4 ↗
Singh Jesse GFBINOther AJuly 1, 2026July 2, 20261d850,000——derivativeForm 4 ↗
Singh Jesse GFBINOther AJuly 1, 2026July 2, 20261d300,000——derivativeForm 4 ↗
Finan IrialFBINOther AJune 29, 2026July 1, 20262d711——Form 4 ↗
GARDEN EDWARD PFBINBuy PJune 10, 2026June 11, 20261d320,067$41$13.0MindirectForm 4 ↗
GARDEN EDWARD PFBINBuy PMay 20, 2026May 21, 20261d57,400$35$2.0MindirectForm 4 ↗
GARDEN EDWARD PFBINBuy PMay 20, 2026May 20, 20260d5,900$33$196KindirectForm 4 ↗
GARDEN EDWARD PFBINBuy PMay 19, 2026May 20, 20261d403,000$33$13.5MindirectForm 4 ↗
GARDEN EDWARD PFBINOther JMay 19, 2026May 20, 20261d373,741——indirectForm 4 ↗
PUGLIESE STEPHANIE L.FBINOther AMay 5, 2026May 7, 20262d4,191——Form 4 ↗
Perry Jeffery S.FBINOther AMay 5, 2026May 7, 20262d4,191——Form 4 ↗
MACKAY A D DAVIDFBINOther AMay 5, 2026May 7, 20262d4,191——Form 4 ↗
Kilsby Susan SFBINOther AMay 5, 2026May 7, 20262d4,191——Form 4 ↗
HACKETT ANN FFBINOther AMay 5, 2026May 7, 20262d4,191——Form 4 ↗
GARDEN EDWARD PFBINOther AMay 5, 2026May 7, 20262d4,765——indirectForm 4 ↗
Foley Brendan MFBINOther AMay 5, 2026May 7, 20262d4,191——Form 4 ↗
Finan IrialFBINOther AMay 5, 2026May 7, 20262d4,191——Form 4 ↗
Chande AmeeFBINOther AMay 5, 2026May 7, 20262d4,191——Form 4 ↗
George Ashley E.FBINOther AMay 4, 2026May 6, 20262d6,829——Form 4 ↗
Finan IrialFBINOther AMarch 30, 2026March 31, 20261d1,058——Form 4 ↗
Ries KarenFBINOther AMarch 16, 2026March 18, 20262d5,673——Form 4 ↗
Ries KarenFBINSell FMarch 2, 2026March 3, 20261d221$52$12KForm 4 ↗
Papesh KristinFBINSell FMarch 2, 2026March 3, 20261d1,757$52$92KForm 4 ↗
Novak Matthew EdwardFBINSell FMarch 2, 2026March 3, 20261d1,065$52$56KForm 4 ↗
Lee John Dong GuFBINSell FMarch 2, 2026March 3, 20261d4,545$52$238KForm 4 ↗
Fink Nicholas I.FBINSell FFebruary 28, 2026March 3, 20263d39,340$52$2.1MForm 4 ↗
Donoghue Hiranda SFBINSell FMarch 2, 2026March 3, 20261d5,007$52$262KForm 4 ↗
Ries KarenFBINOther AFebruary 25, 2026February 27, 20262d3,675——derivativeForm 4 ↗
Ries KarenFBINOther AFebruary 25, 2026February 27, 20262d1,246——Form 4 ↗
Papesh KristinFBINOther AFebruary 25, 2026February 27, 20262d13,362——derivativeForm 4 ↗
Papesh KristinFBINOther AFebruary 25, 2026February 27, 20262d13,596——Form 4 ↗
Novak Matthew EdwardFBINOther AFebruary 25, 2026February 27, 20262d8,017——derivativeForm 4 ↗
Novak Matthew EdwardFBINOther AFebruary 25, 2026February 27, 20262d7,251——Form 4 ↗
Lee John Dong GuFBINOther AFebruary 25, 2026February 27, 20262d18,306——derivativeForm 4 ↗
Lee John Dong GuFBINOther AFebruary 25, 2026February 27, 20262d15,273——Form 4 ↗
Donoghue Hiranda SFBINOther AFebruary 25, 2026February 27, 20262d15,366——derivativeForm 4 ↗
Donoghue Hiranda SFBINOther AFebruary 25, 2026February 27, 20262d9,744——Form 4 ↗
Baksht JonathanFBINOther AFebruary 25, 2026February 27, 20262d26,724——derivativeForm 4 ↗
Baksht JonathanFBINOther AFebruary 25, 2026February 27, 20262d18,128——Form 4 ↗
Papesh KristinFBINOther AFebruary 10, 2026February 12, 20262d1,838——Form 4 ↗
Novak Matthew EdwardFBINOther AFebruary 10, 2026February 12, 20262d1,276——Form 4 ↗
Lee John Dong GuFBINOther AFebruary 10, 2026February 12, 20262d6,378——Form 4 ↗
Fink Nicholas I.FBINOther AFebruary 10, 2026February 12, 20262d58,321——Form 4 ↗
Donoghue Hiranda SFBINOther AFebruary 10, 2026February 12, 20262d7,289——Form 4 ↗
Finan IrialFBINOther AJanuary 2, 2026January 5, 20263d588——Form 4 ↗
Papesh KristinFBINSell FDecember 11, 2025December 12, 20251d303$52$16KForm 4 ↗
Finan IrialFBINOther ASeptember 29, 2025October 1, 20252d564——Form 4 ↗

Federal contracts (USAspending, awards started in the last 180 days)

No contract award starting in the last 180 days was found for a recipient named exactly "Fortune Brands Innovations, Inc.". Subsidiaries and differently-spelled recipients are not matched — search contracts.

Lobbying (Senate LDA, as client)

PeriodRegistrantPrimary issueAmountSource
2026 Q2MCLARTY INBOUND LLCTrade (domestic/foreign)$50,000LDA ↗
2026 Q2MCLARTY INBOUND LLCTrade (domestic/foreign)—LDA ↗
2026 Q1PENN AVENUE PARTNERSTrade (domestic/foreign)$20,000LDA ↗
2025 Q4PENN AVENUE PARTNERSTrade (domestic/foreign)$50,000LDA ↗
2025 Q3PENN AVENUE PARTNERSTrade (domestic/foreign)$50,000LDA ↗

Companies whose stock was traded by the same people who traded FBIN, by number of filers in common. It shows overlap in public filings and nothing else.

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
House Clerk, periodic transaction reports47November 4, 2025June 5, 2026House Clerk search
SEC EDGAR, Form 44458October 1, 2025September 29, 2026Form 4 list on EDGAR
Lobbying disclosure filings5 filings———LDA.gov search

Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.

Not investment advice. Public records shown as filed; no recommendation is made or implied.